Skip to main content
Clinical Trials/NCT02576184
NCT02576184
Completed
Not Applicable

Mesh Reinforcement During Temporary Stoma Closure After Sphincter-Saving Rectal Cancer Surgery: A Randomized-controlled Trial

Assistance Publique - Hôpitaux de Paris1 site in 1 country381 target enrollmentDecember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Incisional Hernia After Diverting Stoma Closure
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
381
Locations
1
Primary Endpoint
radiological incisional hernia rate
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study aim to assess long-term results of an incisional hernia-prophylactic mesh placement during stoma reversal after total mesorectal excision (TME) for rectal cancer

Detailed Description

This study aim to assess long-term results of an incisional hernia-prophylactic mesh placement during stoma reversal after TME for rectal cancer. Patients are randomized in 3 groups : no mesh, synthetic mesh (Parietex, Covidien), biologic mesh (Cellis, Meccelis). Meshes are placed in retromuscular position after diverting ileostomy closure. Primary endpoint is radiological incisional hernia rate, assessed on CT-scan, at the end of follow-up Secondary endpoints include postoperative morbidity, postoperative pain, postoperative quality of life, long-term clinical incisional hernia rate.

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
November 15, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18
  • Operated on for diverting ileostoma closure after sphincter saving rectal cancer surgery, irrespective of the time delay between ileostoma closure and rectal cancer surgery
  • Signed consent
  • Affiliation to the French social security system

Exclusion Criteria

  • Emergency surgery
  • History of laparotomy before ileostoma closure.
  • Surgery associated to the ileostoma closure, excluding appendectomy or liver biopsy
  • Lactating or pregnant woman
  • Allergy to porcine product or collagen-based product. Allergy to polypropylene.
  • Participation to another protocol focusing on ileostoma closure

Outcomes

Primary Outcomes

radiological incisional hernia rate

Time Frame: up to 36 months

Primary endpoint is radiological incisional hernia rate, assessed on CT-scan, at the end of follow-up. Statistical analysis will be performed as soon as follow-up reach 12 months for last included patient

Secondary Outcomes

  • Postoperative morbidity(30 days)
  • Postoperative pain(36 months)
  • Postoperative rehospitalization(36 months)
  • Postoperative reintervention(36 months)
  • Clinical incisional hernia rate(36 months)
  • Quality of life (The Short Form (36) Health Survey score)(12 months)

Study Sites (1)

Loading locations...

Similar Trials